Table 5.

Subgroup analysis according to urine protein.

Variables	No. of studies	No. of participants	SMD [95%CI]	P value
Duration
< 12 weeks	10	191	-1.66 [-2.05, -1.27]	0.16
?12 weeks	8	166	-1.01 [-1.84, -0.18]
Dosage
High dose	12	239	-1.60 [-1.98, -1.22]	0.32
Medium dose	5	94	-0.93 [-2.30, 0.45]
Low dose	1	24	-0.98 [-1.83, -0.12]
Models of animals
Type 1 DN	8	138	-1.16 [-2.11, -0.21]	0.52
Type 2 DN	10	219	-1.50 [-1.91, -1.09]